A 2025 Department of Health and Human Services contingency plan estimated that 47% of Centers for Medicare and Medicaid Services (CMS) staff would be furloughed if government funding lapsed on October 1, 2025.
October 01, 2025
high
statistic
Workforce impact estimated in an HHS shutdown contingency plan.
The Endocrine Society states that the use of puberty-delaying medication or hormone therapy in children is rare and reflects a cautious approach, and that medical treatment is considered appropriate for transgender and gender-diverse teenagers who experience persistent gender dysphoria; the society also cites medical studies indicating that access to such care improves the well-being of transgender and nonbinary people.
2025
high
temporal
Position and summary claim from a major medical specialty society regarding clinical practice and evidence about outcomes.
Puberty blockers, cross-sex (cross-sex) hormones, and surgical procedures are types of medical interventions used to alter a minor's biological sex or to treat pediatric gender dysphoria.
high
temporal
General description of common medical interventions associated with gender-affirming care for children and adolescents.